Skip to main content
Orexo logo

Orexo — Investor Relations & Filings

Ticker · ORX ISIN · SE0000736415 LEI · 549300LJ5CCWDPTK9Z08 ST Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2008-03-04 AGM Information
Country SE Sweden
Listing ST ORX

About Orexo

https://orexo.com/

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Recent filings

Filing Released Lang Actions
AGM Information 2008
AGM Information Classification · 99% confidence The document is explicitly titled "Notice of Annual General Meeting in Orexo AB" and details the date, location, procedures for shareholder participation (including proxy rules), and a detailed proposed agenda for the meeting. The agenda items cover the election of the chairman, approval of financial statements, discharge from liability, determination of board/auditor fees, and proposals regarding share plans and management remuneration. These elements are the core components of a notice for an Annual General Meeting (AGM). Although it mentions the presentation of the annual report (item 7), the document itself is the formal summons and proposal document for the meeting, not the full Annual Report (10-K) or a standalone Audit Report (AR). Therefore, the most appropriate classification is AGM Information.
2008-03-04 English
Interim / Quarterly Report 2007
Interim / Quarterly Report Classification · 95% confidence The document is a 'bokslutskommuniké' (year-end report) for Orexo AB for the period January-December 2007. It contains comprehensive financial statements, including income statements, proforma results, and detailed management commentary on business performance, acquisitions (Biolipox), and clinical trial progress. As it covers a full fiscal year and provides substantive financial data and analysis, it is classified as an Interim/Quarterly Report (IR) in the context of European financial reporting standards where year-end reports are distinct from the full audited Annual Report (10-K). FY 2007
2008-02-15 Swedish
Audit Report / Information 2007
Audit Report / Information Classification · 98% confidence The document is explicitly titled "Orexo AB (publ.) – Year-end Report January-December 2007" and contains comprehensive financial tables covering the full 12 months of 2007, including revenues, loss after tax, and earnings per share, along with management commentary and key events. This structure and content strongly indicate a full annual financial report. Although it is not explicitly labeled '10-K' (which is the SEC filing equivalent), in the context of general corporate filings, a 'Year-end Report' detailing the full fiscal year's performance aligns best with the definition of an Annual Report (10-K). Since the document is extensive (over 80,000 characters) and contains the full results, it is the report itself, not just an announcement of the report (RPA/RNS). FY 2007
2008-02-15 English
Report Publication Announcement 2008
Report Publication Announcement Classification · 99% confidence The document is a press release dated January 15, 2008, titled "Orexo AB – Financial calendar 2008". It explicitly lists the preliminary dates for the release of quarterly reports, the Full Year Report for 2007, and the date for the Annual General Meeting (AGM). Since this document is an announcement about the *timing* of future reports and meetings, rather than the reports themselves (like 10-K, IR, or ER), it fits the definition of a Report Publication Announcement (RPA). The document length is short (1587 chars), supporting the 'MENU VS MEAL' rule, as it announces when reports will be published.
2008-01-15 English
Report Publication Announcement 2008
Report Publication Announcement Classification · 99% confidence The document is a press release from Orexo AB dated January 15, 2008, titled 'Orexo AB – finansiell kalender 2008' (Orexo AB – financial calendar 2008). It explicitly lists the planned dates for quarterly reports (Kvartalsrapport Q4 2007, Q1 2008, Q2 2008, Q3 2008) and the Annual General Meeting (Ordinarie Årsstämma). Since the document's sole purpose is to announce the schedule and timing of future corporate events and reports, it fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports.
2008-01-15 Swedish
Regulatory Filings 2008
Regulatory Filings Classification · 92% confidence The document is titled "Pressmeddelande" (Press Release) dated January 10, 2008, announcing that Orexo's research on eosinophils and their role in asthma/COPD has been published in PNAS. It details the scientific findings, the status of their drug development program (OX-2477), and future plans for strategic collaborations. This is a typical announcement of a significant scientific/research development, often released to the public and investors via a press release format. Since it is not a formal regulatory filing like a 10-K, a quarterly report (IR), or a specific financial event announcement (like DIV or CAP), and it is not a transcript (CT) or a management discussion (MDA), the most appropriate general category for a significant, non-standard corporate announcement that is not a formal report is 'Regulatory Filings' (RNS) as a fallback, or potentially an 'Investor Presentation' (IP) if it were structured as a slide deck, but the format strongly suggests a press release announcing research progress. Given the options, and that it is a general corporate announcement about research progress rather than a specific financial report or mandatory filing, RNS (Regulatory Filings/General Announcement) is the best fit, although it shares characteristics with an ER (Earnings Release) in its announcement nature, but focuses on R&D, not earnings. Since RNS is the general regulatory/announcement fallback, I will use that.
2008-01-10 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.